Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma

Cancer Genetics

Volumn 206, Issue 5, 2013, Pages 206-210

  Cheung, Mitchell ^a   Talarchek, Jacqueline ^a   Schindeler, Karen ^b   Saraiva, Eduardo ^c   Penney, Lynette S ^d   Ludman, Mark ^d,e   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b IWK HEALTH CENTRE   (Canada)

^c C Hospitalar de V N Gaia   (Portugal)

^d DALHOUSIE UNIVERSITY   (Canada)

^e MEIR MEDICAL CENTER   (Israel)

Author keywords

BAP1; Cancer susceptibility; Cutaneous melanoma; Mesothelioma; Uveal melanoma

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; BAP1 GENE; CANCER SUSCEPTIBILITY; CASE REPORT; CUTANEOUS MELANOMA; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; LUNG CANCER; MALIGNANT MESOTHELIOMA; MELANOMA; NONSENSE MEDIATED MRNA DECAY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; UVEA MELANOMA;

BAP1; CANCER SUSCEPTIBILITY; CUTANEOUS MELANOMA; MESOTHELIOMA; UVEAL MELANOMA;

CODON, NONSENSE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MESOTHELIOMA; PEDIGREE; RNA STABILITY; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84881234340     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.05.018     Document Type: Article

References (18)

1. Carbone M., Ly B.H., Dodson R.F., et al. Malignant mesothelioma: facts, myths, and hypotheses. JCell Physiol 2012, 227:44-58.
2. Flores R.M., Pass H.I., Seshan V.E., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. JThorac Cardiovasc Surg 2008, 135:620-626.
3. Woodman S.E. Metastatic uveal melanoma: biology and emerging treatments. Cancer J 2012, 18:148-152.
4. Singh A.D., Turell M.E., Topham A.K. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011, 118:1881-1885.
5. Jensen D.E., Proctor M., Marquis S.T., et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998, 16:1097-1112.
6. Harbour J.W., Onken M.D., Roberson E.D., et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010, 330:1410-1413.
7. Bott M., Brevet M., Taylor B.S., et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011, 43:668-672.
8. Testa J.R., Cheung M., Pei J., et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011, 43:1022-1025.
9. Wiesner T., Obenauf A.C., Murali R., et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011, 43:1018-1021.
10. Abdel-Rahman M.H., Pilarski R., Cebulla C.M., et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. JMed Genet 2011, 48:856-859.
11. Njauw C.N., Kim I., Piris A., et al. Germline BAP1 inactivation ispreferentially associated with metastatic ocular melanoma andcutaneous-ocular melanoma families. PLoS One 2012, 7:e35295.
12. Wadt K., Choi J., Chung J.Y., et al. Acryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res 2012, 25:815-818.
13. Wiesner T., Murali R., Fried I., et al. Adistinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 2012, 36:818-830.
14. Aoude L.G., Vajdic C.M., Kricker A., et al. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases. Pigment Cell Melanoma Res 2013, 26:278-279.
15. Wiesner T., Fried I., Ulz P., et al. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. JClin Oncol 2012, 30:e337-e340.
16. Hoiom V., Edsgard D., Helgadottir H., et al. Hereditary uveal melanoma: a report of a germline mutation in BAP1. Genes Chromosomes Cancer 2013, 52:378-384.
17. Ribeiro C., Campelos S., Moura C.S., et al. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol 2013, Apr 12. [Epub ahead of print].
18. Popova T., Hebert L., Jacquemin V., et al. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 2013, May 14 [Epub ahead of print].